Radiant is building modular bioreactor systems and proprietary cell line engineering to reduce turnaround time for personalised gene therapies from 12 months to 6–7 weeks. The Brisbane biotech team includes researchers from UQ's IMB and aims to serve emerging rare disease treatment networks. Currently developing partnerships with two major gene therapy developers.